Noticias de PSTV_US

Noticias del mercado

Últimas noticias sobre PSTV_US — 164 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: PSTV_US ✕ 164 resultados
15/04/2026 PSTV_US — Investing.com
Plus Therapeutics appoints Randy Goodman to lead market access
15/04/2026 PSTV_US — citybiz
Plus Therapeutics Hires Randy Goodman to Lead Market Access and Value Strategy
15/04/2026 PSTV_US — GlobeNewswire
Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as
10/04/2026 PSTV_US — MSN
Plus Therapeutics recives Nasdaq delinquency notice
10/04/2026 PSTV_US — Benzinga
Why Is Plus Therapeutics Stock Gaining Friday? - Plus Therapeutics (NASDAQ:PSTV)
09/04/2026 PSTV_US — Stock Titan
Plus Therapeutics taps ex-Kiora executive to help push CNS cancer pipeline
09/04/2026 PSTV_US — Stock Titan
Plus Therapeutics (PSTV) hires Eric J. Daniels as Chief Development Officer with equity package
09/04/2026 PSTV_US — GlobeNewswire
Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline
09/04/2026 PSTV_US — GuruFocus
PSTV: Ascendiant Capital Lowers Price Target to $65 on Plus Ther
09/04/2026 PSTV_US — Investing.com
Plus Therapeutics names Eric Daniels as chief development officer
09/04/2026 PSTV_US — Yahoo Finance
Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline
09/04/2026 PSTV_US — TipRanks
Plus Therapeutics Appoints New Chief Development Officer
09/04/2026 PSTV_US — Investing.com
Plus Therapeutics names Eric Daniels as chief development officer By Investing.com
08/04/2026 PSTV_US — Yahoo Finance
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas
08/04/2026 PSTV_US — Investing.com
Plus Therapeutics stock gains after FDA orphan drug nod
08/04/2026 PSTV_US — Investing.com
FDA grants orphan drug status to Plus Therapeutics’ REYOBIQ
08/04/2026 PSTV_US — Stock Titan
FDA grants Orphan Drug Designation to REYOBIQ from Plus Therapeutics (PSTV)
08/04/2026 PSTV_US — Stock Titan
FDA orphan status backs Plus drug for rare childhood brain tumors
08/04/2026 PSTV_US — GlobeNewswire
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas
07/04/2026 PSTV_US — Yahoo Finance
D. Boral Capital Downgrades Plus Therapeutics (PSTV) to Hold

Página 6 de 9

keyboard_arrow_up